COVID-19 vaccine elicits antibodies in 90 percent taking immunosuppressants, study finds
Nearly 90 percent of people taking immunosuppressants to treat autoimmune conditions produce an antibody response to COVID-19 vaccination, but the response is weaker than those generated by healthy people, according to a new study.
Read Original Article: COVID-19 vaccine elicits antibodies in 90 percent taking immunosuppressants, study finds »
